Lineage Cell Therapeutics (LCTX.TA) Q3 2024 Earnings

Aug 8Confirmed
Q4 2023
Q2 2024
Q3 2024
-17.04
-11.37
-5.7
-0.03

Details

Expected EPS
-17.042489999999997
Actual EPS
-11.361659999999999
Surprise EPS
5.68
Surprise Percent
+33.33%

Description

⁨Lineage Cell Therapeutics⁩ (⁦LCTX.TA⁩) has reported earnings of ⁦-11.361659999999999⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts